Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pityriasis lichenoides et varioliformis acuta
ADR ID BADD_A04749
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.02      Skin autoimmune disorders NEC
10.04.02.010      Pityriasis lichenoides et varioliformis acuta
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.08      Papulosquamous conditions
23.03.08.002      Pityriasis lichenoides et varioliformis acuta
Description A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis. [MeSH]
MedDRA Code 10048895
MeSH ID D017514
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Pityriasis lichenoides et varioliformis acuta | Mucha-Habermann disease | Acute parapsoriasis varioliformis | Pityriasis Lichenoides | Pityriasis Lichenoides Chronica | Pityriasis Lichenoides, Chronic | Chronic Pityriasis Lichenoides | Pityriasis Lichenoides et Varioliformis Acuta | Pityriasis Lichenoides, Acute | Acute Pityriasis Lichenoides | Mucha-Habermann Disease | Disease, Mucha-Habermann | Mucha Habermann Disease | Habermann's Disease | Disease, Habermann's | Habermanns Disease | Habermann Disease | Disease, Habermann
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00560Cytarabine0.000112%
BADD_D02093Sulfasalazine--
The 1th Page    1    Total 1 Pages